16. Yoshioka Y, Ogawa K, Oikawa H, Onishi H, Uchida N, Maebayashi T, Kanesaka N, Tamamoto T, Asakura H, Kosugi T, Hatano K, Yoshimura M, Yamada K, Tokumaru S, Sekiguchi K, Kobayashi M, Soejima T, Isohashi F, Nemoto K, Nishimura Y; Japanese Radiation Oncology Study Group. Factors influencing survival outcome for radiotherapy for biliary tract cancer: a multicenter retrospective study. Radiother Oncol. 110(3):546-52, 2014

17. Ohno Y, Nishio M, Koyama H, Miura S, Yoshikawa T, Matsumoto S, Sugimura K. Dynamic contrast-enhanced CT and MRI for pulmonary nodule assessment. AJR Am J Roentgenol. 202(3):515-29, 2014

18. Tanaka N, Asakawa I, Katayama E, Hirayama A, Hasegawa M, Konishi N, Fujimoto K. The biochemical recurrence-free rate in patients who underwent prostate low-dose-rate brachytherapy, using two different definitions. Radiat Oncol. 9:107, 2014

19. Yoshioka Y, Ogawa K, Oikawa H, Onishi H, Kanesaka N, Tamamoto T, Kosugi T, Hatano K, Kobayashi M, Ito Y, Takayama M, Takemoto M, Karasawa K, Nagakura H, Imai M, Kosaka Y, Yamazaki H, Isohashi F, Nemoto K, Nishimura Y; Japanese Radiation Oncology Study Group (JROSG). Impact of intraluminal brachytherapy on survival outcome for radiation therapy for unresectable biliary tract cancer: a propensity-score matched-pair analysis. Int J Radiat Oncol Biol Phys. 89(4):822-9, 2014

20. Ochi T, Taoka T, Matsuda R, Sakamoto M, Akashi T, Tamamoto T, Sugimoto T, Sakaguchi H, Hasegawa M, Nakase H, Kichikawa K. Comparison between two separate injections and a single injection of double-dose contrast medium for contrast-enhanced MR imaging of metastatic brain tumors. Magn Reson Med Sci. 13(4):221-9, 2014

21. Miyake M, Tanaka N, Asakawa I, Morizawa Y, Anai S, Torimoto K, Aoki K, Yoneda T, Hasegawa M, Konishi N, Fujimoto K. Proposed salvage treatment strategy for biochemical failure after radical prostatectomy in patients with prostate cancer: a retrospective study. Radiat Oncol. 9:208, 2014

22. Hori S, Tanaka N, Asakawa I, Morizawa Y, Hirayama A, Hasegawa M, Konishi N, Fujimoto K. Salvage brachytherapy for seminal vesicle recurrence after initial brachytherapy for prostate cancer: a case report. BMC Res Notes. 7:760, 2014

23. Tanaka N, Torimoto K, Asakawa I, Miyake M, Anai S, Hirayama A, Hasegawa M, Konishi N, Fujimoto K. Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer – a randomized controlled trial of silodosin versus naftopidil. Radiat Oncol. 9:302, 2014